Vaccines, Blood & Biologics
?
-
Menomune-A/C/Y/W-135
STN: BL 103926/5159
Proper Name: Meningococcal Polysaccharide Vaccine, Groups A, C, Y, W135 Combined
Tradename: Menomune-A/C/Y/W-135
Manufacturer: Sanofi Pasteur Inc, License #1725
Indication:
- For active immunization against invasive meningococcal disease caused by Neisseria meningiditis serogroups A, C, Y, and W-135. Menomune – A/C/Y/W-135 vaccine is approved for use in persons 2 years of age and older.
-
Supporting Documents
October 19, 2012 Approval Letter - Menomune-A/C/Y/W-135
To include updated information in the Dosage and Administration section of the package insert.June 13, 2012 Approval Letter - Menomune-A/C/Y/W-135
To update the package insert by changing the wording from a "suspension" to a clear "solution" based on the current master specification.January 9, 2009 Approval Letter - Menomune-A/C/Y/W-135
-
-
-
